Showing results (31-40 of 171) with videos related to
Sort By:
Pageof 18
The Journal of Experimental Medicine|November 1, 1986
Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cellsT Kinoshita, M E Medof, K Hong, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytesG M Kammer, E I Walter, M E MedofClinical and Experimental Immunology|June 1, 1982
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cellsM E Medof, G M Prince, J J OgerProceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factorM E Medof, T Kinoshita, R Silber, et al.Archives of Biochemistry and Biophysics|August 23, 2001
Bulk production and functional analyses of mouse CD55's native and deglycosylated active domainsF Lin, R M Immormino, M Shoham, et al.The Journal of Clinical Investigation|September 1, 1993
Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsR H Wang, G Phillips, M E Medof, et al.Current Eye Research|January 14, 1998
Detection of complement regulatory proteins on soft contact lensesD S Bardenstein, S Sauer, L Szczotka, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cellsS Hirose, L Ravi, S V Hazra, et al.Protein Engineering|December 1, 1996
Molecular modeling and mechanism of action of human decay-accelerating factorL Kuttner-Kondo, M E Medof, W Brodbeck, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cellsM E Medof, T Lam, G M Prince, et al.Pageof 18